SLC2A1 and prostate carcinoma: Carreño et al. explored the metabolic pathways of fructose in prostate cancer cells, noting that despite low expression of Glut-1, these cells efficiently utilize fructose to support proliferation and growth, with fructose metabolism potentially promoting cancer cell proliferation through de novo lipogenesis pathways 99.